- Home
- ESEA vs JUNS Comparison
ESEA vs JUNS Comparison
Compare ESEA & JUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESEA
- JUNS
- Stock Information
- Founded
- ESEA 2005
- JUNS 2015
- Country
- ESEA Greece
- JUNS United States
- Employees
- ESEA N/A
- JUNS N/A
- Industry
- ESEA Marine Transportation
- JUNS
- Sector
- ESEA Consumer Discretionary
- JUNS
- Exchange
- ESEA Nasdaq
- JUNS NYSE
- Market Cap
- ESEA 235.7M
- JUNS 281.4M
- IPO Year
- ESEA 2006
- JUNS 2024
- Fundamental
- Price
- ESEA $32.50
- JUNS $0.61
- Analyst Decision
- ESEA Buy
- JUNS
- Analyst Count
- ESEA 1
- JUNS 0
- Target Price
- ESEA $53.00
- JUNS N/A
- AVG Volume (30 Days)
- ESEA 35.6K
- JUNS 156.8K
- Earning Date
- ESEA 02-27-2025
- JUNS 05-11-2025
- Dividend Yield
- ESEA 8.00%
- JUNS N/A
- EPS Growth
- ESEA N/A
- JUNS N/A
- EPS
- ESEA 16.20
- JUNS N/A
- Revenue
- ESEA $212,897,313.00
- JUNS N/A
- Revenue This Year
- ESEA $4.65
- JUNS N/A
- Revenue Next Year
- ESEA $4.36
- JUNS N/A
- P/E Ratio
- ESEA $2.05
- JUNS N/A
- Revenue Growth
- ESEA 12.43
- JUNS N/A
- 52 Week Low
- ESEA $30.21
- JUNS $0.55
- 52 Week High
- ESEA $50.92
- JUNS $19.51
- Technical
- Relative Strength Index (RSI)
- ESEA 44.74
- JUNS N/A
- Support Level
- ESEA $31.75
- JUNS N/A
- Resistance Level
- ESEA $33.95
- JUNS N/A
- Average True Range (ATR)
- ESEA 1.47
- JUNS 0.00
- MACD
- ESEA -0.10
- JUNS 0.00
- Stochastic Oscillator
- ESEA 18.29
- JUNS 0.00
About ESEA Euroseas Ltd. (Marshall Islands)
Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.
About JUNS JUPITER NEUROSCIENCES INC
Jupiter Neurosciences Inc is a clinical stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a unique resveratrol platform product primarily targeting treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to most central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.